Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 3
2006 2
2007 1
2008 1
2009 1
2010 1
2011 7
2012 4
2013 4
2014 6
2015 4
2016 4
2017 2
2018 2
2019 2
2020 5
2021 3
2022 5
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report.
Corrado D, Anastasakis A, Basso C, Bauce B, Blomström-Lundqvist C, Bucciarelli-Ducci C, Cipriani A, De Asmundis C, Gandjbakhch E, Jiménez-Jáimez J, Kharlap M, McKenna WJ, Monserrat L, Moon J, Pantazis A, Pelliccia A, Perazzolo Marra M, Pillichou K, Schulz-Menger J, Jurcut R, Seferovic P, Sharma S, Tfelt-Hansen J, Thiene G, Wichter T, Wilde A, Zorzi A. Corrado D, et al. Int J Cardiol. 2024 Jan 15;395:131447. doi: 10.1016/j.ijcard.2023.131447. Epub 2023 Oct 14. Int J Cardiol. 2024. PMID: 37844667 Free article.
Arrhythmogenic cardiomyopathy (ACM) is a heart muscle disease characterized by prominent "non-ischemic" myocardial scarring predisposing to ventricular electrical instability. Diagnostic criteria for the original phenotype, arrhythmogenic right vent …
Arrhythmogenic cardiomyopathy (ACM) is a heart muscle disease characterized by prominent "non-ischemic" myocardial scarring predispos …
Management of arrhythmogenic right ventricular cardiomyopathy.
Silvano M, Mastella G, Zorzi A, Migliore F, Pilichou K, Bauce B, Rigato I, Perazzolo Marra M, Iliceto S, Thiene G, Basso C, Corrado D. Silvano M, et al. Minerva Med. 2016 Aug;107(4):194-216. Epub 2016 May 17. Minerva Med. 2016. PMID: 27186923 Review.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetically determined heart muscle disorder, predisposing to sudden cardiac death (SCD), particularly in young patients and athletes. Pathological features include loss of myocytes and fibrofatty re …
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetically determined heart muscle disorder, predisposing …
Clinical screening and genetic testing.
Deo RC, MacRae CA. Deo RC, et al. Clin Lab Med. 2010 Dec;30(4):775-84. doi: 10.1016/j.cll.2010.07.003. Clin Lab Med. 2010. PMID: 20832651 Free PMC article. Review.
Evidence-based management of arrhythmogenic right ventricular cardiomyopathy in pregnancy.
Khosla J, Golamari R, Cai A, Benson J, Aronow WS, Jain R, Jain R. Khosla J, et al. Future Cardiol. 2021 Jul;17(4):693-703. doi: 10.2217/fca-2020-0127. Epub 2020 Oct 22. Future Cardiol. 2021. PMID: 33089714
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder resulting in fibrofatty replacement of the myocardium. Genetic mutations in genes encoding for desmosome proteins result in a ventricular myocardium prone to arrhythmias and h …
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder resulting in fibrofatty replacement of the …
A novel genotype-based clinicopathology classification of arrhythmogenic cardiomyopathy provides novel insights into disease progression.
Chen L, Song J, Chen X, Chen K, Ren J, Zhang N, Rao M, Hu Z, Zhang Y, Gu M, Zhao H, Tang H, Yang Z, Hu S. Chen L, et al. Eur Heart J. 2019 Jun 1;40(21):1690-1703. doi: 10.1093/eurheartj/ehz172. Eur Heart J. 2019. PMID: 30945739
AIMS: Arrhythmogenic cardiomyopathy (AC) shows large heterogeneity in its clinical, genetic, and pathological presentation. ...Precordial QRS amplitude is an independent indicator reflecting the right ventricular remodelling, which may be able to predict tran …
AIMS: Arrhythmogenic cardiomyopathy (AC) shows large heterogeneity in its clinical, genetic, and pathological presentation. ...Precor …
Genotype-phenotype correlation in arrhythmogenic right ventricular cardiomyopathy-risk of arrhythmias and heart failure.
Christensen AH, Platonov PG, Jensen HK, Chivulescu M, Svensson A, Dahlberg P, Madsen T, Frederiksen TC, Heliö T, Lie ØH, Haugaa KH, Hastrup Svendsen J, Bundgaard H. Christensen AH, et al. J Med Genet. 2022 Sep;59(9):858-864. doi: 10.1136/jmedgenet-2021-107911. Epub 2021 Aug 16. J Med Genet. 2022. PMID: 34400560
BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is predominantly caused by desmosomal genetic variants, and clinical hallmarks include arrhythmias and systolic dysfunction. ...Reduced left ventricular ejection fraction (LVEF) 45% on …
BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is predominantly caused by desmosomal genetic varian …
Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy.
Christensen AH, Platonov PG, Svensson A, Jensen HK, Rootwelt-Norberg C, Dahlberg P, Madsen T, Frederiksen TC, Heliö T, Haugaa KH, Bundgaard H, Svendsen JH. Christensen AH, et al. Europace. 2022 Feb 2;24(2):306-312. doi: 10.1093/europace/euab112. Europace. 2022. PMID: 34279601
AIMS: Treatment with implantable cardioverter-defibrillators (ICD) is a cornerstone for prevention of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy (ARVC). We aimed at describing the complications associated with ICD treatment in a m …
AIMS: Treatment with implantable cardioverter-defibrillators (ICD) is a cornerstone for prevention of sudden cardiac death in arrhythmoge …
Arrhythmogenic cardiomyopathy and differential diagnosis with physiological right ventricular remodelling in athletes using cardiovascular magnetic resonance.
Moccia E, Papatheodorou E, Miles CJ, Merghani A, Malhotra A, Dhutia H, Bastiaenen R, Sheikh N, Zaidi A, Sanna GD, Homfray T, Bunce N, Anderson LJ, Tome M, Behr E, Moon J, Sharma S, Finocchiaro G, Papadakis M. Moccia E, et al. Int J Cardiovasc Imaging. 2022 Dec;38(12):2723-2732. doi: 10.1007/s10554-022-02684-y. Epub 2022 Jul 21. Int J Cardiovasc Imaging. 2022. PMID: 36445664
To describe the overlap between structural abnormalities typical of arrhythmogenic right ventricular cardiomyopathy (ARVC) and physiological right ventricular adaptation to exercise and differentiate between pathologic and physiologic findings u …
To describe the overlap between structural abnormalities typical of arrhythmogenic right ventricular cardiomyopathy (AR …
Advances in the diagnostic management of arrhythmogenic right ventricular dysplasia-cardiomyopathy.
Peters S. Peters S. Int J Cardiol. 2006 Oct 26;113(1):4-11. doi: 10.1016/j.ijcard.2005.12.015. Epub 2006 Jun 5. Int J Cardiol. 2006. PMID: 16737750 Review.
Latest advances in the diagnostic management of arrhythmogenic right ventricular dysplasia-cardiomyopathy (ARVD/C) confirm that ARVD/C is not a rare disease (one affected in 1000-1250 inhabitants) and is of familial origin in 50-80% of cases. ...Up to …
Latest advances in the diagnostic management of arrhythmogenic right ventricular dysplasia-cardiomyopathy (ARVD/ …
Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype-phenotype correlation study.
Segura-Rodríguez D, Bermúdez-Jiménez FJ, Carriel V, López-Fernández S, González-Molina M, Oyonarte Ramírez JM, Fernández-Navarro L, García-Roa MD, Cabrerizo EM, Durand-Herrera D, Alaminos M, Campos A, Macías R, Álvarez M, Tercedor L, Jiménez-Jáimez J. Segura-Rodríguez D, et al. Eur Heart J Cardiovasc Imaging. 2020 Apr 1;21(4):378-386. doi: 10.1093/ehjci/jez277. Eur Heart J Cardiovasc Imaging. 2020. PMID: 31702781 Free article.
AIMS: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a life-threatening entity with a highly heterogeneous genetic background. ...Next-generation sequencing identified a potential pathogenic mutation in 71.4% of the proban …
AIMS: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a life-threatening entity with a hig …
52 results